Brompton Announces Special Meetings of Dividend Growth

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
38
Brompton Announces Special Meetings of Dividend Growth Split Corp. and Brompton Split Banc Corp.

TORONTO, July 16, 2018 (GLOBE NEWSWIRE) -- (TSX: DGS ) (TSX:DGS.PR.A) (TSX: SBC ) (TSX:SBC.PR.A) Brompton Funds Limited ( “Brompton ” or the “Manager” ), announces special meetings (the “ Meetings ” and each, a “Meeting” ) of holders of Class A Shares and Preferred Shares (the “ Shareholders ”) of Dividend Growth Split Corp. (“ DGS ”) and Brompton Split Banc Corp (“ SBC ”). The purpose of the Meetings is to consider and vote upon extraordinary resolutions to implement amendments to update and modernize the investment objectives, investment strategies and investment restrictions of DGS and SBC (the “Amendments” ).  DGS and SBC were launched in December 2007 and November 2005, respectively. 

Changes Proposed for DGS

DGS invests, on an equally weighted basis, in a portfolio consisting of common shares of 20 high dividend growth rate Canadian companies.  DGS provides a low cost, efficient way to gain exposure to high dividend growth rate Canadian companies, with the added benefit of a proprietary covered call strategy employed by Brompton which lowers portfolio volatility along with generating cash flows for distribution to shareholders.  Since inception on December 3, 2007 to June 30, 2018, Class A Shares and Preferred Shares have generated annualized compound returns of 7.4%, and 5.4%, respectively.  The Class A Shares have outperformed the S&P/TSX Composite Index by 2.7% per annum since inception. (1)

The Manager believes that the dividend growth strategy continues to offer compelling value and is well positioned to benefit from the growing Canadian and global economies.  The Manager believes that certain changes are advisable to the investment objectives, strategy and restrictions of DGS to expand its investment universe for high quality dividend growth companies. The Manager believes that the proposed changes should enhance long-term returns and are in the best interests of shareholders.  The proposed changes to the investment objectives, strategy and restrictions are primarily designed to accomplish the following:

  1. expand the investable universe of high quality dividend growth companies from which the portfolio manager can select by expanding the financial metrics that may be used to analyze the portfolio constituents, including forward-looking metrics and to allow the Manager to adjust the portfolio more frequently other than under exceptional circumstances;  
  2. provide for up to 20% of the portfolio to be invested, from time to time, in global dividend growth companies; and  
  3. allow the Manager to rebalance and/or reconstitute the portfolio more frequently than annually, at its discretion, for reasons other than the suspension of dividends, mergers or fundamental corporate actions or exceptional circumstances, so that DGS may respond to security or market developments on a timely basis.

The management fee will not be increased for DGS because of the additional work associated with these enhancements.

Changes Proposed for SBC

SBC invests, on an equally weighted basis, in a portfolio consisting of common shares of the six largest Canadian banks.   SBC provides a low cost, efficient way to gain exposure to the six largest Canadian banks, with the added benefit of a proprietary covered call strategy employed by Brompton which lowers portfolio volatility along with generating attractive cash flows for distribution to shareholders.  Since inception on November 16, 2005 to June 30, 2018, Class A Shares and Preferred Shares have generated annualized compound returns of 11.6%, and 5.1%, respectively.  The Class A Shares have outperformed the S&P/TSX Capped Financials Index by 3.4% per annum and the S&P/TSX Composite Index by 5.2% per annum since inception. (2)

The Manager believes that a portfolio consisting primarily of the six largest Canadian banks continues to offer compelling value and is well positioned to benefit from the growing Canadian and global economies and rising interest rates.  The six largest Canadian banks which are currently Bank of Montreal, Royal Bank of Canada, Canadian Imperial Bank of Commerce, The Bank of Nova Scotia, National Bank of Canada and The Toronto-Dominion Bank, have dominant positions in the Canadian banking sector and in 2017 Canada’s banks were ranked among the soundest in the world by the World Economic Forum.    However, given the rapidly changing nature of global financial services and their regulatory environments, the Manager believes that certain modest changes are advisable to the investment objectives, strategy and restrictions of SBC to expand its investment universe.  The Manager believes that the proposed changes should enhance long-term returns and are in the best interests of shareholders.  The proposed changes to the investment objectives, strategy and restrictions are primarily designed to accomplish the following:

  1. allow the Manager to rebalance and/or reconstitute the portfolio more frequently than annually, at its discretion, for reasons other than mergers or fundamental corporate actions, so that SBC may respond to security or market developments on a timely basis; and  
  2. provide for up to 10% of the portfolio to be invested, from time to time, in global financial companies.

The management fee will not be increased for SBC because of the additional work associated with these enhancements.

Special meetings of Shareholders will be held on August 29, 2018 to consider and vote on the proposed Amendments.  Shareholders of record at the close of business on July 30, 2018 will be entitled to vote at the meetings.  The Manager expects the effective date of the Amendments to take place shortly after the meetings.  Details of the proposed Amendments will be further outlined in the DGS and SBC notices of meeting and management information circular that will be prepared and delivered to Shareholders in connection with the special meetings and will be available on www.sedar.com .

About Brompton Funds Brompton Funds, a division of Brompton Group which was founded in 2000, is an experienced investment fund manager with approximately $2 billion in assets under management. Brompton’s investment solutions include TSX traded funds, mutual funds and flow-through limited partnerships.  For further information, please contact your investment advisor, call Brompton’s investor relations line at 416-642-6000 (toll-free at 1-866-642-6001), email info@bromptongroup.com or visit our website at www.bromptongroup.com .

(1) See performance table below.

  1 Year   3 Years   5 Years   10 Years   Since Inception  
 Performance as at June 30, 2018*                 Dec. 3/07  
Dividend Growth Split Corp. – Class A Shares (3.9%)   8.3%   12.1%   10.6%   7.4%  
Dividend Growth Split Corp. – Preferred Shares 5.4%   5.4%   5.4%   5.4%   5.4%  
Dividend Growth Split Corp. – Unit 1.9%   6.5%   8.2%   7.7%   6.0%  
S&P/TSX Composite Index 10.4%   6.9%   9.2%   4.2%   4.7%  

(2) See performance table below.

  1 Year   3 Years   5 Years   10 Years   Since Inception  
 Performance as at June 30, 2018**                 Nov. 16/05  
Brompton Split Banc Corp. – Class A Shares 15.4%   18.7%   20.2%   16.6%   11.6%  
Brompton Split Banc Corp. – Preferred Shares 4.9%   4.7%   4.7%   5.0%   5.1%  
Brompton Split Banc Corp. – Unit 11.2%   12.7%   13.2%   11.2%   8.7%  
S&P/TSX Capped Financials Index 8.9%   10.9%   12.7%   9.6%   8.2%  
S&P/TSX Composite Index 10.4%   6.9%   9.2%   4.2%   6.4%  
                     

*The table shows DGS’ compound return on a Class A share, Preferred share and unit for each period indicated, compared with the S&P/TSX Composite Index (‘‘Composite Index’’). The Composite Index tracks the performance of a broad index of large-capitalization issuers listed on the TSX. DGS invests in a passively managed portfolio of 20 companies that is rebalanced at least annually. It is therefore not expected DGS’ performance will mirror that of the Composite Index, which has a more diversified portfolio. The Composite Index is calculated without the deduction of management fees, fund expenses and trading commissions, whereas the performance of the DGS’ performance is calculated after deducting such fees and expenses.  Further, the performance of DGS’ Class A shares is impacted by the leverage provided by its Preferred shares.

**The table shows SBC’s compound return on a Class A share, Preferred share and unit for each period indicated compared with the S&P/TSX Capped Financials Index (‘‘Financials Index’’) and the S&P/TSX Composite Index (‘‘Composite Index’’). The Financials Index is derived from the Composite Index based on the financials sector of the Global Industry Classification Standard.  The Composite Index tracks the performance, on a market weight basis, of a broad index of large-capitalization issuers listed on the TSX.  SBC passively invests on an equal weight basis in a portfolio comprised of six Canadian banks which are in both the Financials Index and the Composite Index.  Since the indices have more diversified portfolios, it is not expected that SBC’s performance will mirror that of the indices. The Financials Index and Composite Index returns are calculated without the impact of management fees, fund expenses and trading commissions, whereas the performance of SBC’s Class A shares and units are calculated after deducting such fees and expenses.  Further, the performance of SBC’s Class A shares is impacted by the leverage provided by SBC’s Preferred shares.

You will usually pay brokerage fees to your dealer if you purchase or sell shares of an investment fund on the Toronto Stock Exchange or other alternative Canadian trading system (an “exchange”).  If the shares are purchased or sold on an exchange, investors may pay more than the current net asset value when buying shares of an investment fund and may receive less than the current net asset value when selling them.

There are ongoing fees and expenses associated with owning shares of an investment fund.  An investment fund must prepare disclosure documents that contain key information about DGS and SBC.  You can find more detailed information about DGS and SBC in the public filings available at www.sedar.com.  The indicated rates of return are the historical annual compounded returns including changes in share value and reinvestment of all distributions and do not take into account certain fees such as redemption costs or income taxes payable by any securityholder that would have reduced returns.  Investment funds are not guaranteed, their values change frequently and past performance may not be repeated.

Certain statements contained in this news release constitute forward-looking information within the meaning of Canadian securities laws. Forward-looking information may relate to matters disclosed in this press release and to other matters identified in public filings relating to the Fund, to the future outlook of DGS or SBC and anticipated events or results and may include statements regarding the future financial performance of DGS or SBC.  In some cases, forward-looking information can be identified by terms such as “may”, “will”, “should”, “expect”, “plan”, “anticipate”, “believe”, “intend”, “estimate”, “predict”, “potential”, “continue” or other similar expressions concerning matters that are not historical facts.  Actual results may vary from such forward-looking information. Investors should not place undue reliance on forward-looking statements.  These forward-looking statements are made as of the date hereof and we assume no obligation to update or revise them to reflect new events or circumstances.

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Fuse Oncology Showcases New iRT Workflow at ASTRO

Updated Category News Views 4

Revolutionizing Charge Capture in Oncology Fuse Oncology's latest showcase at the ASTRO 2026 Annual Meeting isn't just about flashy presentations—it's looking to change how radiation oncology departments handle complex workflows. If you've ever delved into the maze of oncology billing, you know it's rife with opportunities for errors and inefficiencies. Skip one charge,...

Continue Reading
Leo Cancer Care's Upright Radiotherapy Milestone

Updated Category News Views 4

Upright Radiotherapy: Breaking Tradition in Cancer Care Here's a twist in the world of cancer treatment folks weren't exactly expecting. Leo Cancer Care has flipped the script by taking radiotherapy from a concept to an actual clinical reality with their Upright Platform. Yes, we're talking about standing up while getting treated, and it's not just a gimmick—it's a game...

Continue Reading
Quay Shines in 2026 Prescription Sunglasses Lineup

Updated Category News Views 5

Spotlight on Quay: A Fashion-Forward Prescription Glasses that make you look good and actually correct your vision? That's the holy grail right there. Consumer365 just put Quay front and center in their 2026 rundown of the best prescription sunglasses out there. Let's break this down and see what's got folks buzzing. Diving into Style and Substance Now, if you're like me,...

Continue Reading
DKS Facing Class Action Over Stock Slump Allegations

Updated Category News Views 3

A Burst Bubble at DICK'S Sporting Goods Grit your teeth and hang on—DICK'S Sporting Goods has stumbled, and investors are supposed to just weather the storm. From September 8, 2025, through August 24, 2026, if you held DICK'S shares, you've got some explaining to do, or at least you better start reading the fine print. Take note, folks: the deadline to file for lead...

Continue Reading
Accuray, Samsung Push Boundaries with Imaging Deal

Updated Category News Views 3

In a move that's got the healthcare industry buzzing, Accuray Incorporated (NASDAQ: ARAY) announced its partnership with Samsung NeuroLogica to supercharge the CyberKnife® System. This isn't just another collaboration; it's a strategic pivot to advance imaging capabilities, marrying Samsung's volumetric innovations with Accuray's established precision in robotic...

Continue Reading
Melrose Fire Station Reaches Steel Topping Milestone

Updated Category News Views 3

Metal and Milestones: A New Era for Melrose Rolling into Melrose, Massachusetts, there's some serious action kicking off with the new Fire Engine 2 Station reaching a steel topping milestone. This phase isn't just about slapping on another beam; it's the crescendo of diligent teamwork from all the hands involved—from CTA Construction Managers to the clout of Ironworkers...

Continue Reading
IASO's FUCASO Shows Robust Results in 2026 Study

Updated Category News Views 6

IASO's Groundbreaking Results Stir Ripples in Oncology Folks, let me paint the picture here with the mighty, nitty-gritty details straight from the heart of China. The 2026 IMS Annual Meeting held a gem that could redefine how investors see the course of hematologic malignancy treatments. IASO Bio dropped some heavy data, showing their fine product, FUCASO, in a...

Continue Reading
AI Memory Growth Pushes Limits at GMIF2026 Summit

Updated Category News Views 3

The Memory and Storage Race in the AI Era The 5th GMIF2026 Innovation Summit wrapped up in Shenzhen, and boy, was it a heavyweight bout. You could practically feel the tension in the room as industry giants sparred over the future of memory and storage in AI. This wasn't just another trade show pow-wow; this was a strategic chess match over where AI infrastructure is...

Continue Reading
Salveo Home Care Faces Class Action Over Labor Violations

Updated Category News Views 5

Another Company Lands in Hot Water Alright, it looks like Salveo Home Care is in the spotlight for all the wrong reasons. The home care provider—which should have been minding its P's and Q's—is now facing a class action suit. Why, you ask? Well, for allegedly skimping on wages and dodging legal obligations that leave their employees hanging dry. The Allegations are...

Continue Reading
Revamping Children's Radiotherapy: Leo Cancer Care's Vision

Updated Category News Views 5

The latest buzz in pediatric radiotherapy is shaking things up, and it’s all thanks to a game-changing shift in how treatment is delivered to kids. We're eyeballing Leo Cancer Care's innovative approach that might just redefine how these young patients face their battles. Standing Tall: A New Chapter in Proton Therapy In June, Stanford Medicine dished out the first...

Continue Reading

Top 5 Most Recently Viewed Articles

Hargreave Hale AIM VCT PLC: New Share Allotment Explained

Updated Category News Views 114

Understanding the Latest Allotment of Shares for Hargreave Hale AIM VCT PLC Recently, Hargreave Hale AIM VCT PLC, known for its investment strategy focusing on AIM-listed companies, announced exciting developments regarding its share allotment. A prospectus was published for the offer of subscription for ordinary shares, aiming to raise up to £20 million. This initiative...

Continue Reading
Minovia Therapeutics Secures FDA Fast Track for MNV-201 Use

Updated Category News Views 203

Minovia's Remarkable Achievement in Myelodysplastic Syndrome Minovia Therapeutics Ltd. has made significant strides in the realm of biotechnology by receiving Fast Track Designation from the U.S. Food and Drug Administration (FDA) for its investigational compound, MNV-201. This designation is pivotal as MNV-201 aims to treat Myelodysplastic Syndrome (MDS), a serious and...

Continue Reading
Transforming Cybersecurity Training into Measurable Investment

Updated Category News Views 160

The Importance of Cybersecurity Training With the rise of cyber threats, it's essential for organizations to understand why investing in cybersecurity training is crucial. Companies like INE Security offer vital insights into how to effectively assess the return on investment (ROI) for these training initiatives. Cybersecurity training isn't merely a means of protection;...

Continue Reading
Inspirato Set to Reveal Q3 2024 Financial Results Soon

Updated Category News Views 79

Upcoming Q3 2024 Results Announcement Inspirato Incorporated (NASDAQ: ISPO), recognized as a premier luxury vacation club, has scheduled its release of financial and operating results for the third quarter of 2024. This announcement is anticipated to take place after market closure on Monday. As an entity that redefines luxury travel experiences, this news is particularly...

Continue Reading
Piedmont Lithium Reports Impressive Q4’24 Operational Results

Updated Category News Views 83

Piedmont Lithium's Stellar Q4 2024 Performance Piedmont Lithium Inc. (NASDAQ: PLL) has announced impressive operational results for the fourth quarter of 2024, marking a crucial step in the company's commitment to the North American lithium supply chain. The company successfully shipped approximately 55,700 dry metric tons (dmt) of spodumene concentrate during this...

Continue Reading